Novel Therapeutics Track

Development of novel therapeutics (small molecule or biologics), medical devices, and diagnostics for unmet medical needs

Novel Therapeutics Track
  • Overview
  • Requirements
  • Application
  • Key Dates


SPARK TEL AVIV is a mentoring program created to accelerate scientific discoveries with a high potential impact on therapeutics by bridging the gap between academic research and the healthcare industry.


Our mission is to help researchers from TAU and affiliated hospitals overcome the obstacles involved in moving their early discoveries from bench to bedside by directing and facilitating their translational research.



Novel Therapeutics Track:

Novel Therapeutics Track offers grants for the development of small molecule or biologics, medical devices and diagnostics for unmet medical needs.


The program will support expenses needed for taking the project toward implementation, including market survey, regulatory consultancy, medicinal chemistry support, product design, and engineering efforts required for reaching commercial quality and clinical readiness.


Admitted projects will receive milestone-based funds to support and de-risk each project, up to $100,000 per project/year, for a maximum of 2 years. Funded projects will receive continuous education programs, mentorship, and access to expert advisors at all stages of product development.


For the call for proposal PDF version click here >>


Your Benefits:

  • Project management support and mentorship
  • Fund to support and de-risk your project
  • Advice from industry leaders
  • Education on drug development, medical devices and diagnostics 
  • Participation in a community of inventors and entrepreneurs
  • Access to investors and experts with commercialization experience
  • Membership in the international SPARK network
  • Support for bringing your invention to the clinic
Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>